Scilex Holding Company, a Sorrento Company, announces continued growth in ZTlidoÂ® in managed health care plans
globenewswire.com
news
2022-06-02 00:00:00

Earlier this year, a national pharmacy benefit manager (PBM) moved a large percentage of its patients from not covered to covered, adding access to ZTlido for 5.5 million lives. ZTlido is now covered by managed health care plans representing approximately 190 million of the over 300 million covered lives across the United States1. PALO ALTO, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company ('Scilex'), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc.
